Abstract

To realize three-dimensional (3D) optical imaging of the internal structure of an animal body, we have developed a new technique to reconstruct optical computed tomography (optical CT) images from two-dimensional (2D) transillumination images. In transillumination imaging of an animal body using near-infrared light, the image is blurred because of the strong scattering in the tissue. To overcome this problem, we propose a novel technique to apply the point spread function (PSF) for a light source located inside the medium to the transilluminated image of light-absorbing structure. The problem of the depth-dependence of PSF was solved in the calculation of the projection image in the filtered back-projection method. The effectiveness of the proposed technique was assessed in the experiments with a model phantom and a mouse. These analyses verified the feasibility of the practical 3D imaging of the internal light-absorbing structure of a small animal.

© 2014 Optical Society of America

1. Introduction

Three-dimensional imaging with X-ray or MRI has contributed greatly not only to medical diagnosis, but also to life science. The number of experimental animals killed for experimentation would be reduced if we were able to visualize the animals’ internal structures non-invasively. In transillumination imaging using near-infrared (NIR) light, we can visualize the location of internal bleeding, infection, and angiogenesis [112]. Functional imaging is also possible using spectroscopic principles [423]. With specific contrast media, the usefulness of NIR imaging is expanded significantly.

The possibility and the potential of the NIR transillumination technique were pointed out early [13], but the technique has not been used widely. The major reason for that relative lack of use is the difficulty of the strong scattering in tissues [112]. In transillumination images, the deeper structure is blurred and cannot be differentiated from the shallower and less-absorbing structure. To overcome this problem, great effort has been undertaken to develop optical computed tomography (optical CT) techniques. The typical technique for a macroscopic structure is diffuse optical tomography (DOT) [2434]. Using this technique, cross-sectional imaging of human breasts and infant heads was achieved. Once the cross-sectional images become available, 3D imaging is possible. However, current techniques require great computational effort such as finite element method calculation, and large devices such as numerous fiber bundles around the object body.

We would be able to reconstruct the 3D structure with a common filtered back-projection algorithm and with a CCD or CMOS camera if we were able to suppress the scattering effect in transillumination images effectively. They require much simpler and more compact device as well as much less computational effort.

For scattering suppression, the deconvolution technique using the point spread function (PSF) is effective. We have derived the PSF for the fluorescent light source by applying the diffusion approximation to the equation of transfer [35]. With the known depth of the light source in a diffuse medium, we can recover the fluorescent distribution clearly through an interstitial tissue by the deconvolution with this PSF. Therefore, we could expect to realize the 3D imaging from the transillumination images if we were able to apply this light-source PSF to the absorbing structure and thereby solve the problem of the depth-dependence of the PSF.

In this paper, we propose the 3D imaging of internal absorbing structure of a small experimental animal from 2D NIR transillumination images using new scatter-suppression techniques.

2. Scattering suppression by PSF deconvolution

For the fluorescent point source at depth d as shown in Fig. 1, the PSF is given as [35],

PSF(ρ)=3P0(4π)2{(μ's+μa)+[κd+1(ρ2+d2)1/2]d(ρ2+d2)1/2}exp[κd(ρ2+d2)1/2](ρ2+d2)1/2,
where P0, μ's, μa, d, and ρ respectively stand for the optical power of a point source, the reduced scattering coefficient, the absorption coefficient, the depth of a point source, and the radial distance in the cylindrical coordinate system. κd=3μa(μ's+μa).

 

Fig. 1 Geometry for PSF as light distribution observed at the scattering medium surface.

Download Full Size | PPT Slide | PDF

This PSF was obtained as the light image from a point light source observed at the scattering medium surface. Therefore, its applicability to the transillumination image of an absorbing structure must be examined. In transillumination imaging, homogeneous light is irradiated from outside of the scattering medium. The scattered light goes through the absorbing structure and projects the shadow on the surface of the scattering medium. We can consider the absorber as a collection of light-missing points if the light is diffused well at the depth of the absorbing structure. Then the absorber image observed at the surface is the collection of the spread light-missing distributions which are the PSFs obtained above. We can apply the Eq. (1) to the transillumination image of an absorbing structure if this assumption is correct.

The applicability described above was assessed in an experiment. Figure 2 shows the experimental system. As a scattering medium, an Intralipid suspension (Fresenius Kabi AG) was mixed with distilled water and black ink (INK-30-B; Pilot Corp.) to produce a tissue-equivalent medium (μ's = 1.00 /mm, μa = 0.01 /mm). As an absorbing structure, a square black-painted metal plate (10.0 × 10.0 × 1.00 mm3) was used. This absorber was placed in an acrylic container (40.0 × 100 × 100 mm3) filled with scattering medium. The depth of the absorber from the observation surface was variable from 4.00 to 14.0 mm. This phantom was irradiated with the NIR light from a laser (Ti:Sapphire, 800 nm wavelength) through a beam expander for homogeneous illumination. An image is obtained using a cooled CMOS camera (C11440-10C; Hamamatsu Photonics K.K.) oriented toward the opposite face of the phantom to the light-incident side.

 

Fig. 2 Experimental setup for transillumination imaging: d = 4.00–14.0 mm.

Download Full Size | PPT Slide | PDF

We first obtained a transillumination image fo(x, y) of an absorbing object in a transparent medium, or clear water. Subsequently, we replaced the water with the scattering medium, and obtained the transillumination image fs(x, y). The measured PSF for the absorbing structure PSFabs(x, y) was calculated as

PSFabs(x,y)=fs(x,y)fo(x,y),
where denotes the deconvolution operation.

The measured PSFabs(x, y) was compared with the theoretical PSF of the fluorescent source or Eq. (1) using the same conditions as those of the experiment. Figure 3 shows the comparison of PSF at depth d = 8.00 mm. Figures 3(a), 3(b), 3(c), and 3(d) respectively show the observed transillumination image with the scattering medium fs(x, y), with the transparent medium fo(x, y), measured PSF for absorbing structure PSFabs(x, y) calculated from Eq. (2), and PSF calculated from Eq. (1). Figures 3(c) and 3(d) show good agreement between the PSFabs from Eq. (2) and the PSF from Eq. (1). Figure 4 shows the result of the comparison in terms of the spread (FWHM) of these two PSFs. At the same depth d, both PSFs were in good agreement.

 

Fig. 3 Comparison of point spread function at depth d = 8.00 mm: (a) fs(x, y), (b) fo(x, y), (c) PSFabs(x, y) from Eq. (2), (d) PSF from Eq. (1).

Download Full Size | PPT Slide | PDF

 

Fig. 4 Comparison between theoretical PSF for light source and measured PSF for absorber.

Download Full Size | PPT Slide | PDF

Through this analysis, it was confirmed that the depth-dependent PSF for the fluorescent light source is applicable to the transillumination images of the absorbing structure.

Experimental verification of scattering suppression

The effectiveness of the PSF from Eq. (1) to suppress the scattering effect in a transillumination image of the absorbing structure was examined in another experiment. In the deconvolution process, the Lucy–Richardson algorithm [36,37] with iteration number up to 10 was used.

A Y-shaped black tube (4.00 mm diameter) was placed at 4.00 mm depth from the observation surface. Figure 5(a) shows the image through clear water. Figures 5(b) and 5(c) respectively show the observed transillumination image and the result of deconvolution with the PSF at 4.00 mm depth. The separation of Y-shaped arms was clarified by the deconvolution with an appropriate PSF. The effectiveness is apparent in the intensity profiles shown in Fig. 6 as well. The average Michelson contrasts were, respectively, 0.31 and 0.77 for observed and deconvoluted images. The sharpness parameters of these images were respectively, 0.18 and 0.54 for observed and deconvoluted images.

 

Fig. 5 Transillumination image: (a) original object, (b) observed image, (c) deconvoluted image.

Download Full Size | PPT Slide | PDF

 

Fig. 6 Intensity profiles along the dashed line in Fig. 5.

Download Full Size | PPT Slide | PDF

Through this experimental analysis, it was confirmed that the PSF derived for a fluorescent light source is applicable and effective to suppress the scattering effect in transillumination images.

3. 3D reconstruction from transillumination images

3.1 Tissue-equivalent phantom

Considering a transillumination image as a projection in the computed tomography, one can reconstruct the 3D structure of the internal absorption distribution of a turbid medium. The feasibility of this 3D reconstruction was examined in an experiment. Figures 7 and 8 show the experimental setup and the target structure of this experiment. A slant cylindrical post (3.00 mm diameter, 30.6 mm length) was fixed in the acrylic container (35.0 × 100 × 100 mm3) filled with a scattering medium. Intralipid suspension (Fresenius Kabi AG) was mixed with distilled water to produce tissue-equivalent medium (μ's = 1.00 /mm, μa = 0.00536 /mm). Laser light (Ti:Sapphire, 850 nm wavelength) was illuminated from one side of the container and the transillumination image was recorded using a cooled CMOS camera (C11440-10C; Hamamatsu Photonics K.K.) from another side of the container. This recording was repeated while rotating the absorber post around the rotation axis shown in Fig. 8 using a mechanical rotary motion system.

 

Fig. 7 Experimental setup.

Download Full Size | PPT Slide | PDF

 

Fig. 8 Side view and top view of phantom model.

Download Full Size | PPT Slide | PDF

In this case, the depth of the absorber from the observing surface of the scattering medium was not constant along the vertical axis of rotation. Therefore, the PSFs with known different depths were applied to a transillumination image, and horizontal intensity profiles were extracted at the proper vertical heights in the improved image obtained by the proper PSF with the correct depth. These horizontal intensity profiles were obtained from different circumferential orientations. The cross-sectional image was reconstructed using the filtered back-projection algorithm. Finally, we piled up the cross-sectional images along the vertical axis and reconstructed the 3D structure.

Figure 9 shows the observed transillumination image and the result of the PSF deconvolution. In this case, the absorbing post was parallel to the observation surface, and we were able to use the PSF with a single depth. The observed image was degraded severely by the effect of strong scattering. Its effect was greatly suppressed when using the proposed technique. Figures 10 and 11 show the cross-sectional images reconstructed from the observed and deconvoluted transillumination images. With the observed images, the position of the absorber was difficult to identify in cross-sectional images. They became clearly identifiable using the proposed technique. We analyzed the accuracy of the cross-sectional image at 10 different heights. The reconstruction error in the estimated depth d^ in the improved cross-sectional images varied 0.25–2.97% along the vertical axis.

 

Fig. 9 Observed and deconvoluted images of absorber: (a) observed image (contrast and sharpness are 0.10 and 0.020), (b) deconvoluted image (contrast and sharpness are 0.90 and 0.71).

Download Full Size | PPT Slide | PDF

 

Fig. 10 CT image at the top of the absorber: (a) from observed images, (b) from deconvoluted images. Depth of estimated absorber center (d^) was 9.35 mm for true depth 9.08 mm.

Download Full Size | PPT Slide | PDF

 

Fig. 11 CT image at the bottom of the absorber: (a) from observed images, (b) from deconvoluted images. Depth of estimated absorber center (d^) was 12.1 mm for true depth 12.2 mm.

Download Full Size | PPT Slide | PDF

Figure 12 shows the result of the 3D reconstruction. The absorbing structure in tissue-equivalent medium was reconstructed clearly using the proposed technique.

 

Fig. 12 3D Reconstruction of absorber in turbid medium: (a) from observed images, (b) from deconvoluted images, (c) result of thresholding on image (b) with a single threshold value.

Download Full Size | PPT Slide | PDF

3.2 Animal-tissue phantom

To validate the accuracy of the result in heterogeneous animal tissue, 3D imaging was attempted with known absorbing structure. The method of the experiment was the same as that with the tissue-equivalent phantom mentioned above. A black-painted slant cylindrical post (3.00 mm diameter, 30.1 mm length) was fixed in the rectangular container filled with chicken breast meat. A transparent acrylic cylindrical tube (30.0 mm diameter, 2.00 mm wall thickness) rotated the post around the rotation axis.

Figure 13 shows an example of the transillumination image at 0 degree and the result of the proposed technique. The scattering effect was suppressed efficiently, and the absorbing objects were visualized. The center of the absorber was estimated in the cross-sectional images at 10 different heights. The estimation errors of the center varied 1.35–2.72% along the vertical axis. Figure 14 shows the result of 3D reconstruction. Using the proposed technique, the absorbing structure was reconstructed clearly in the heterogeneous animal tissue, as well.

 

Fig. 13 Observed and deconvoluted images of absorber at 0-deg orientation: (a) observed image (b) result using the proposed technique.

Download Full Size | PPT Slide | PDF

 

Fig. 14 3D Reconstruction of absorber in animal tissue: (a) from observed images, (b) from deconvoluted images, (c) result of thresholding on image (b) with a single threshold value.

Download Full Size | PPT Slide | PDF

4. Application of depth-dependent PSF for unknown structure

As shown in the previous chapter, we can suppress the scattering effect in transillumination images and reconstruct the structure in a turbid medium. The blurring effect of scattering can be suppressed effectively by deconvolution with the depth-dependent PSF (Eq. (1)). Therefore, this technique is powerful when examining a known discrete structure such as that described in the preceding chapter. However, the structure is often unknown and not as simple as described above. The transillumination image is the integration of all the absorbing distribution in different depths with different blurring. Therefore, the scattering suppression with the PSF at a single depth is not effective for such a case. The usefulness of the proposed method would be expanded greatly if we were able to apply this technique to the object with unknown structure.

To overcome this problem, we developed a new technique to reconstruct a 3D structure from the blurred transillumination images using the depth-dependent PSF. Figure 15 shows the condition of a transillumination image of two absorbing objects at different depth in a turbid medium. The observed image appears as shown in Fig. 15(b). The absorption profile in the observed intensity is shown in the lower part of Fig. 15(b). The developed technique consists of two processes. The first process is the deconvolution of a transillumination image with the PSFs at varying depths. Figure 16 presents this process. The principle is shown in one dimension for simplicity instead of two dimension. All the deconvoluted data are summed to produce the projection data for the filtered back-projection process in the optical CT reconstruction. In this way, the true profile of the absorbing object is included in the projection data. In practice, two-dimensional PSFs at different depths are applied to a 2D transillumination image. The deconvoluted images are summed up to produce a projection image for 3D-optical CT reconstruction.

 

Fig. 15 Two absorbing objects in turbid medium: (a) top view of observing condition, (b) observed transillumination image and absorption profile along the dashed line.

Download Full Size | PPT Slide | PDF

 

Fig. 16 Absorption profiles before and after the deconvolution with PSFs at different depths. The projection is obtained as a sum of the deconvoluted data with the PSFs at different depths. Profile of projection for cross-sectional reconstruction is shown in upper right corner. denotes the deconvolution operation.

Download Full Size | PPT Slide | PDF

This process can be written as

P(x,z|θ)=i=1nA(x,y,z|θ)dyPSF(x,z|di),
where P, A, and PSF respectively represent the functions of projection, blurred absorption distribution and point spread function. denotes the deconvolution operation. (x,y,z), θ and di respectively represent the Cartesian coordinates, orientation of observation, and the i-th depth, respectively. i = 1, 2 …. n, and n is the number of different depths.

As shown in Fig. 16, the sum of the deconvoluted profiles includes erroneous profiles as well as the true profile. They are the results of the deconvolution with the PSFs at shallower depths than the true depths of the absorbing object. The effects of the erroneous profiles are suppressed in the second process of the developed technique. In the second process, we first reconstruct a cross-sectional image from the projection data or the sum of the deconvoluted profiles. This cross-sectional image from the deconvoluted profiles is better than that from the observed profiles, because the profiles at the deeper depths than the true depth were effectively erased by the deconvolution operation as shown in Fig. 16. In this improved cross-sectional image, we sample the absorption profiles at the same depths as those of the PSFs used in the first process. We call this profile an erasing template, E(x,z|θ,di). Then, we multiply these profiles as the templates to erase the unnecessary parts of the deconvoluted profiles. Figure 17 portrays this operation. Consequently, we emphasize the profiles only at the true depths. Then they are summed up to make a new improved projection. This process can be written as

Pnew(x,z|θ)=i=1n[A(x,y,z|θ)dyPSF(x,z|di)]E(x,z|θ,di),
where Pnew, A, PSF, and E respectively show the functions of new projection, blurred absorption distribution, point spread function, and the erasing template.

 

Fig. 17 Principle to suppress erroneous absorption distribution. Erroneous parts are suppressed by multiplying erasing templates obtained from the original cross-sectional image. New projection image is constructed as a sum of the corrected images. * denotes the multiplication operation.

Download Full Size | PPT Slide | PDF

Using the new projection imagePnew(x,z|θ), we can reconstruct an improved 3D image with the filtered back-projection algorithm. This process can be repeated until a satisfactory result is obtained.

The effectiveness of the proposed technique was verified in computer simulation with the model shown in Fig. 18(a). The effect of scattering was suppressed by the proposed technique (number of different depths, n = 300) with a single step of the template erasure process as shown in Figs. 18(b)18(d).

 

Fig. 18 Result of proposed technique in simulation: (a) simulation model (μ's = 1.00 /mm, μa = 0.00536 /mm), (b) cross-sectional image of two objects in scattering medium, (c) result from projection of Eq. (3), (d) result from projection of Eq. (4).

Download Full Size | PPT Slide | PDF

5. Experiment with phantom

The feasibility of the proposed technique, described in previous chapter, was examined in an experiment. Figure 19 presents a schematic of the experimental system to obtain transillumination images of a tissue-equivalent phantom. As scattering medium, Intralipid suspension (Fresenius Kabi AG) and black ink (INK-30-B; Pilot Corp.) were mixed with distilled water to produce a tissue-equivalent medium (μ's = 1.00 /mm, μa = 0.01 /mm). As an absorbing structure, three black-painted objects as shown in Figs. 20(a) and 21(a) were used to simulate the high-absorbing structure in mouse body, such as kidneys and a spleen.

 

Fig. 19 Experimental setup with phantom.

Download Full Size | PPT Slide | PDF

 

Fig. 20 Scattering suppression in transillumination imaging at 0-deg orientation: (a) observed image in clear medium, (b) observed image in scattering medium, (c) result using the proposed technique.

Download Full Size | PPT Slide | PDF

 

Fig. 21 Scattering suppression in transillumination imaging at 90-deg orientation: (a) observed image in clear medium, (b) observed image in scattering medium, (c) result using the proposed technique.

Download Full Size | PPT Slide | PDF

The absorbing structure was placed at the center of an acrylic container (35.0 × 100 × 100 mm3) filled with scattering medium. The phantom was irradiated with the NIR light from a laser (Ti:Sapphire, 850 nm wavelength) through a beam expander for homogeneous illumination. The image was captured using a cooled CMOS camera (C11440-10C; Hamamatsu Photonics K.K.) oriented toward the opposite face of the phantom to the light incident side. This recording was repeated while rotating the absorbing structure around the rotation axis using a mechanical rotation system.

Figures 20(a) and 21(a) respectively show the observed image of the absorbing structure in clear medium at 0 degree and 90 degree. Figures 20(b) and 21(b) show the observed image of the absorbing structure in scattering medium. Figures 20(c) and 21(c) show the result of the process described in chapter 4. The proposed technique was applied with the number of different depths n = 350 and with a single step of the template erasure process. The scattering effect was suppressed efficiently, and the absorbing objects were visualized.

Figure 22 shows results with two-level thresholds, which are common in all the figures. The internal structure, which is hardly seen in Fig. 22(b), became visible by the proposed technique.

 

Fig. 22 3D images reconstructed from transillumination images: (a) from observed image in clear medium, (b) from observed image in scattering medium, (c) result using the proposed technique.

Download Full Size | PPT Slide | PDF

6. 3D imaging of animal body

To examine the applicability of the proposed technique to a living animal body, experiments were conducted with a mouse. Figure 23 shows the experimental setup. A female mouse Slc:ICR (20 weeks old) was anesthetized by the intraperitoneal injection of pentobarbital (Nembutal). The mouse was held in a cylindrical holder made of transparent acrylic resin. Laser light (Ti:Sapphire, 850 nm wavelength) was illuminated from one side of the holder. Then the image was recorded using a CMOS camera (C11440-10C; Hamamatsu Photonics K.K.) from another side.

 

Fig. 23 Setup for experiment with living animal.

Download Full Size | PPT Slide | PDF

Special caution had to be taken to obtain transillumination images. Figure 24(a) presents an example of the transillumination image obtained with the experimental setup shown in Fig. 23. The surface of the mouse was lighted up, and the internal structure could hardly be seen because of the light guide effect of the acrylic cylinder. The incident light was guided through the cylindrical acrylic wall, subsequently illuminating a wide area of the body-surface of the mouse. To prevent this phenomenon, we cut the cylinder half and installed light traps in the cylinder wall. Figure 24(c) presents the light trap structure. Figure 24(b) shows the transillumination image obtained in the same experimental setup (Fig. 23) using the cylindrical mouse holder with light traps. By suppressing body-surface scattering, the internal structure came out in the image. The recording of a transillumination image was repeated while rotating the holder around the rotation axis shown in Fig. 23 using a mechanical rotation system. Figure 25 shows typical transillumination images obtained before and after the scattering suppression of the proposed technique. The internal light-absorbing structure became visible when using the proposed technique. From these transillumination images, the cross-sectional images were reconstructed using the proposed technique described in chapter 4. The proposed technique was applied with the number of different depths n = 350 and with a single step of the template erasure process.

 

Fig. 24 Suppression of body-surface illumination caused by light-guide effect in cylindrical container: (a) without light trap, (b) with light trap, (c) light trap structure.

Download Full Size | PPT Slide | PDF

 

Fig. 25 Transillumination images of mouse abdomen: (a) observed image, (b) deconvoluted image with PSF (μ's = 1.5 /mm, μa = 0.02 /mm).

Download Full Size | PPT Slide | PDF

These cross-sectional images were piled up vertically and a 3D image was constructed. Figure 26 presents results with three-level thresholds. Common thresholds were used for Figs. 26(a) and 26(b). The internal structure hardly seen in Fig. 26(a) became visible using the proposed technique. The high-absorption organs such as kidneys and the bottom parts of the liver were identified.

 

Fig. 26 3D images reconstructed from transillumination images of mouse: (a) from observed images, (b) result using the proposed technique.

Download Full Size | PPT Slide | PDF

This experimental study verified the feasibility of the practical 3D imaging of the internal light-absorbing structure of a small animal.

7. Conclusions

With a view toward the imaging of the internal absorbing structure in an animal body, a new technique was developed to reconstruct the three-dimensional structure from transillumination images. To suppress the blurring effect of scattering in biological tissues, we applied the deconvolution method with a point spread function. Through theoretical and experimental study, we confirmed the applicability of the PSF for the light source to the transillumination images of the light-absorbing structure. We also confirmed the effectiveness of this technique in the experiment with a tissue-equivalent phantom.

The PSF is depth-dependent, and the technique explained above was applicable only for an object with known internal structure. To expand the applicability of this technique, we devised new algorithms. An observed transillumination image is deconvoluted with the PSFs of different depths. Then the deconvoluted images are summed up to produce a new image that serves as a projection image in cross-sectional reconstruction. The projection image contains the projection of the true absorption distribution and the incompletely deconvoluted projection as well. To suppress the effect of this erroneous projection, we devised an erasing process. A cross-sectional image is reconstructed from the projection images obtained from many orientations. It is used as a template to erase the erroneous distribution in the cross-section. After the application of this erasing process, a new improved projection image is formed in which the effect of the erroneous distribution is suppressed effectively.

The feasibility of the proposed technique was examined in a computer simulation and an experiment with a model phantom. The results demonstrated the effectiveness of the proposed technique. Finally, the applicability of the proposed technique to an living animal was examined. An anesthetized mouse was fixed in a transparent cylinder. We devised a light trap in the cylinder to produce a transillumination image of good quality. Using the proposed technique, the 3D structure of the mouse abdomen was reconstructed. High-absorbing organs such as the kidneys and parts of livers became visible.

Results of this study suggest that we can expect a new optical CT having different features from those of currently available techniques such as conventional diffuse optical tomography (DOT) techniques. This simple system can provide a cross-sectional image and reconstruct the 3D structure of internal organ in the mouse body. It can provide a useful and safe tool for the functional imaging of internal organs of experimental animals and for optical CT imaging of the near-surface structure of the human body.

Acknowledgments

A part of this research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The animal experiment in this study was conducted in accordance with the guidelines [38] and with the approval of the review committee for animal experiments at Hokkaido University.

References and links

1. R. Bright, Diseases of the brain and nervous system vol. II (London: Longman, 1831).

2. T. B. Curling, A practical treatise on the diseases of the testis and of the spermatic cord and scrotum (London: Samuel Highley, 1843).

3. M. Cutler, “Transillumination as an aid in the diagnosis of breast lesions,” Surg. Gynecol. Obstet. 48, 721–728 (1929).

4. J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997). [CrossRef]   [PubMed]  

5. R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003). [CrossRef]   [PubMed]  

6. A. H. Hielscher, “Optical tomographic imaging of small animals,” Curr. Opin. Biotechnol. 16(1), 79–88 (2005). [CrossRef]   [PubMed]  

7. A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Phys. Med. Biol. 50(4), R1–R43 (2005). [CrossRef]   [PubMed]  

8. V. Ntziachristos, “Fluorescence molecular imaging,” Annu. Rev. Biomed. Eng. 8(1), 1–33 (2006). [CrossRef]   [PubMed]  

9. A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009). [CrossRef]   [PubMed]  

10. F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010). [CrossRef]   [PubMed]  

11. B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012). [CrossRef]   [PubMed]  

12. J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013). [CrossRef]  

13. F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977). [CrossRef]   [PubMed]  

14. M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988). [CrossRef]   [PubMed]  

15. G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995). [CrossRef]   [PubMed]  

16. E. Okada, M. Firbank, M. Schweiger, S. R. Arridge, M. Cope, and D. T. Delpy, “Theoretical and experimental investigation of near-infrared light propagation in a model of the adult head,” Appl. Opt. 36(1), 21–31 (1997). [CrossRef]   [PubMed]  

17. F. F. Jobsis-Vandervliet, “Discovery of the near-infrared window into the body and the early development of near-infrared spectroscopy,” J. Biomed. Opt. 4(4), 392–396 (1999). [CrossRef]   [PubMed]  

18. Y. Taka, Y. Kato, and K. Shimizu, “Transillumination imaging of physiological functions by NIR light,” in Proceedings of IEEE Conference on 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE, 2000), pp. 771–774. [CrossRef]  

19. H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003). [CrossRef]   [PubMed]  

20. Y. Hoshi, “Functional near-infrared optical imaging: utility and limitations in human brain mapping,” Psychophysiology 40(4), 511–520 (2003). [CrossRef]   [PubMed]  

21. I. Nishidate, Y. Aizu, and H. Mishina, “Depth visualization of a local blood region in skin tissue by use of diffuse reflectance images,” Opt. Lett. 30(16), 2128–2130 (2005). [CrossRef]   [PubMed]  

22. M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007). [CrossRef]   [PubMed]  

23. T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007). [CrossRef]   [PubMed]  

24. A. Y. Bluestone, G. Abdoulaev, C. Schmitz, R. L. Barbour, and A. H. Hielscher, “Three-dimensional optical tomography of hemodynamics in the human head,” Opt. Express 9(6), 272–286 (2001). [CrossRef]   [PubMed]  

25. D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001). [CrossRef]  

26. H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001). [CrossRef]   [PubMed]  

27. A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002). [CrossRef]   [PubMed]  

28. F. Gao, H. Zhao, and Y. Yamada, “Improvement of image quality in diffuse optical tomography by use of full time-resolved data,” Appl. Opt. 41(4), 778–791 (2002). [CrossRef]   [PubMed]  

29. J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002). [CrossRef]   [PubMed]  

30. H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003). [CrossRef]   [PubMed]  

31. J. P. Culver, A. M. Siegel, J. J. Stott, and D. A. Boas, “Volumetric diffuse optical tomography of brain activity,” Opt. Lett. 28(21), 2061–2063 (2003). [CrossRef]   [PubMed]  

32. D. A. Boas, K. Chen, D. Grebert, and M. A. Franceschini, “Improving the diffuse optical imaging spatial resolution of the cerebral hemodynamic response to brain activation in humans,” Opt. Lett. 29(13), 1506–1508 (2004). [CrossRef]   [PubMed]  

33. B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006). [CrossRef]   [PubMed]  

34. L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007). [CrossRef]   [PubMed]  

35. K. Shimizu, K. Tochio, and Y. Kato, “Improvement of transcutaneous fluorescent images with a depth-dependent point-spread function,” Appl. Opt. 44(11), 2154–2161 (2005). [CrossRef]   [PubMed]  

36. D. S. C. Biggs and M. Andrews, “Acceleration of iterative image restoration algorithms,” Appl. Opt. 36(8), 1766–1775 (1997). [CrossRef]   [PubMed]  

37. R. J. Hanisch, R. L. White, and R. L. Gilliland, “Deconvolution of hubble space telescope images and spectra,” in Deconvolution of Images and Spectra, P.A. Jansson, ed. (Academic Press, Boston, MA, 1997).

38. Science Council of Japan, Guidelines for proper conduct of animal experiments (2006).

References

  • View by:
  • |
  • |
  • |

  1. R. Bright, Diseases of the brain and nervous system vol. II (London: Longman, 1831).
  2. T. B. Curling, A practical treatise on the diseases of the testis and of the spermatic cord and scrotum (London: Samuel Highley, 1843).
  3. M. Cutler, “Transillumination as an aid in the diagnosis of breast lesions,” Surg. Gynecol. Obstet. 48, 721–728 (1929).
  4. J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997).
    [Crossref] [PubMed]
  5. R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003).
    [Crossref] [PubMed]
  6. A. H. Hielscher, “Optical tomographic imaging of small animals,” Curr. Opin. Biotechnol. 16(1), 79–88 (2005).
    [Crossref] [PubMed]
  7. A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Phys. Med. Biol. 50(4), R1–R43 (2005).
    [Crossref] [PubMed]
  8. V. Ntziachristos, “Fluorescence molecular imaging,” Annu. Rev. Biomed. Eng. 8(1), 1–33 (2006).
    [Crossref] [PubMed]
  9. A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009).
    [Crossref] [PubMed]
  10. F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
    [Crossref] [PubMed]
  11. B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012).
    [Crossref] [PubMed]
  12. J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
    [Crossref]
  13. F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
    [Crossref] [PubMed]
  14. M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988).
    [Crossref] [PubMed]
  15. G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
    [Crossref] [PubMed]
  16. E. Okada, M. Firbank, M. Schweiger, S. R. Arridge, M. Cope, and D. T. Delpy, “Theoretical and experimental investigation of near-infrared light propagation in a model of the adult head,” Appl. Opt. 36(1), 21–31 (1997).
    [Crossref] [PubMed]
  17. F. F. Jobsis-Vandervliet, “Discovery of the near-infrared window into the body and the early development of near-infrared spectroscopy,” J. Biomed. Opt. 4(4), 392–396 (1999).
    [Crossref] [PubMed]
  18. Y. Taka, Y. Kato, and K. Shimizu, “Transillumination imaging of physiological functions by NIR light,” in Proceedings of IEEE Conference on 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE, 2000), pp. 771–774.
    [Crossref]
  19. H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003).
    [Crossref] [PubMed]
  20. Y. Hoshi, “Functional near-infrared optical imaging: utility and limitations in human brain mapping,” Psychophysiology 40(4), 511–520 (2003).
    [Crossref] [PubMed]
  21. I. Nishidate, Y. Aizu, and H. Mishina, “Depth visualization of a local blood region in skin tissue by use of diffuse reflectance images,” Opt. Lett. 30(16), 2128–2130 (2005).
    [Crossref] [PubMed]
  22. M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
    [Crossref] [PubMed]
  23. T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
    [Crossref] [PubMed]
  24. A. Y. Bluestone, G. Abdoulaev, C. Schmitz, R. L. Barbour, and A. H. Hielscher, “Three-dimensional optical tomography of hemodynamics in the human head,” Opt. Express 9(6), 272–286 (2001).
    [Crossref] [PubMed]
  25. D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
    [Crossref]
  26. H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
    [Crossref] [PubMed]
  27. A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
    [Crossref] [PubMed]
  28. F. Gao, H. Zhao, and Y. Yamada, “Improvement of image quality in diffuse optical tomography by use of full time-resolved data,” Appl. Opt. 41(4), 778–791 (2002).
    [Crossref] [PubMed]
  29. J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
    [Crossref] [PubMed]
  30. H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003).
    [Crossref] [PubMed]
  31. J. P. Culver, A. M. Siegel, J. J. Stott, and D. A. Boas, “Volumetric diffuse optical tomography of brain activity,” Opt. Lett. 28(21), 2061–2063 (2003).
    [Crossref] [PubMed]
  32. D. A. Boas, K. Chen, D. Grebert, and M. A. Franceschini, “Improving the diffuse optical imaging spatial resolution of the cerebral hemodynamic response to brain activation in humans,” Opt. Lett. 29(13), 1506–1508 (2004).
    [Crossref] [PubMed]
  33. B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
    [Crossref] [PubMed]
  34. L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007).
    [Crossref] [PubMed]
  35. K. Shimizu, K. Tochio, and Y. Kato, “Improvement of transcutaneous fluorescent images with a depth-dependent point-spread function,” Appl. Opt. 44(11), 2154–2161 (2005).
    [Crossref] [PubMed]
  36. D. S. C. Biggs and M. Andrews, “Acceleration of iterative image restoration algorithms,” Appl. Opt. 36(8), 1766–1775 (1997).
    [Crossref] [PubMed]
  37. R. J. Hanisch, R. L. White, and R. L. Gilliland, “Deconvolution of hubble space telescope images and spectra,” in Deconvolution of Images and Spectra, P.A. Jansson, ed. (Academic Press, Boston, MA, 1997).
  38. Science Council of Japan, Guidelines for proper conduct of animal experiments (2006).

2013 (1)

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

2012 (1)

B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012).
[Crossref] [PubMed]

2010 (1)

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

2009 (1)

A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009).
[Crossref] [PubMed]

2007 (3)

M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
[Crossref] [PubMed]

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007).
[Crossref] [PubMed]

2006 (2)

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

V. Ntziachristos, “Fluorescence molecular imaging,” Annu. Rev. Biomed. Eng. 8(1), 1–33 (2006).
[Crossref] [PubMed]

2005 (4)

2004 (1)

2003 (5)

H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003).
[Crossref] [PubMed]

J. P. Culver, A. M. Siegel, J. J. Stott, and D. A. Boas, “Volumetric diffuse optical tomography of brain activity,” Opt. Lett. 28(21), 2061–2063 (2003).
[Crossref] [PubMed]

R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003).
[Crossref] [PubMed]

H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003).
[Crossref] [PubMed]

Y. Hoshi, “Functional near-infrared optical imaging: utility and limitations in human brain mapping,” Psychophysiology 40(4), 511–520 (2003).
[Crossref] [PubMed]

2002 (3)

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

F. Gao, H. Zhao, and Y. Yamada, “Improvement of image quality in diffuse optical tomography by use of full time-resolved data,” Appl. Opt. 41(4), 778–791 (2002).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

2001 (3)

A. Y. Bluestone, G. Abdoulaev, C. Schmitz, R. L. Barbour, and A. H. Hielscher, “Three-dimensional optical tomography of hemodynamics in the human head,” Opt. Express 9(6), 272–286 (2001).
[Crossref] [PubMed]

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

1999 (1)

F. F. Jobsis-Vandervliet, “Discovery of the near-infrared window into the body and the early development of near-infrared spectroscopy,” J. Biomed. Opt. 4(4), 392–396 (1999).
[Crossref] [PubMed]

1997 (3)

1995 (1)

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

1988 (1)

M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988).
[Crossref] [PubMed]

1977 (1)

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

1929 (1)

M. Cutler, “Transillumination as an aid in the diagnosis of breast lesions,” Surg. Gynecol. Obstet. 48, 721–728 (1929).

Abdoulaev, G.

Abdoulaev, G. S.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Aizu, Y.

Andrews, M.

Arridge, S. R.

L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007).
[Crossref] [PubMed]

A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Phys. Med. Biol. 50(4), R1–R43 (2005).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997).
[Crossref] [PubMed]

E. Okada, M. Firbank, M. Schweiger, S. R. Arridge, M. Cope, and D. T. Delpy, “Theoretical and experimental investigation of near-infrared light propagation in a model of the adult head,” Appl. Opt. 36(1), 21–31 (1997).
[Crossref] [PubMed]

Austin, T.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Barbour, R. L.

Baron, L.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Basevi, H. R. A.

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

Beuthan, J.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Biggs, D. S. C.

Bluestone, A. Y.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

A. Y. Bluestone, G. Abdoulaev, C. Schmitz, R. L. Barbour, and A. H. Hielscher, “Three-dimensional optical tomography of hemodynamics in the human head,” Opt. Express 9(6), 272–286 (2001).
[Crossref] [PubMed]

Boas, D. A.

Brooks, D. H.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Brooksby, B. A.

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

Chance, B.

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

Chen, K.

Cho, E.

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Cope, M.

E. Okada, M. Firbank, M. Schweiger, S. R. Arridge, M. Cope, and D. T. Delpy, “Theoretical and experimental investigation of near-infrared light propagation in a model of the adult head,” Appl. Opt. 36(1), 21–31 (1997).
[Crossref] [PubMed]

M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988).
[Crossref] [PubMed]

Corballis, P. M.

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Culver, J. P.

Cutler, M.

M. Cutler, “Transillumination as an aid in the diagnosis of breast lesions,” Surg. Gynecol. Obstet. 48, 721–728 (1929).

D’Alessandro, B.

B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012).
[Crossref] [PubMed]

Davis, S. C.

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

Dehghani, H.

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009).
[Crossref] [PubMed]

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003).
[Crossref] [PubMed]

Delpy, D. T.

L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997).
[Crossref] [PubMed]

E. Okada, M. Firbank, M. Schweiger, S. R. Arridge, M. Cope, and D. T. Delpy, “Theoretical and experimental investigation of near-infrared light propagation in a model of the adult head,” Appl. Opt. 36(1), 21–31 (1997).
[Crossref] [PubMed]

M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988).
[Crossref] [PubMed]

Dhawan, A. P.

B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012).
[Crossref] [PubMed]

DiMarzio, C. A.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Douek, M.

Eggert, J.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Enfield, L. C.

Everdell, N.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Everdell, N. L.

Fabiani, M.

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Fajardo, L.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Ferrari, M.

M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
[Crossref] [PubMed]

Firbank, M.

Frampton, J.

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

Franceschini, M. A.

Gao, F.

Gaudette, R. J.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Gibson, A.

A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Gibson, A. P.

Gratton, G.

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Grebert, D.

Guggenheim, J. A.

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

Hamaoka, T.

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

Hebden, J. C.

L. C. Enfield, A. P. Gibson, N. L. Everdell, D. T. Delpy, M. Schweiger, S. R. Arridge, C. Richardson, M. Keshtgar, M. Douek, and J. C. Hebden, “Three-dimensional time-resolved optical mammography of the uncompressed breast,” Appl. Opt. 46(17), 3628–3638 (2007).
[Crossref] [PubMed]

A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Phys. Med. Biol. 50(4), R1–R43 (2005).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997).
[Crossref] [PubMed]

Hielscher, A. H.

A. H. Hielscher, “Optical tomographic imaging of small animals,” Curr. Opin. Biotechnol. 16(1), 79–88 (2005).
[Crossref] [PubMed]

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

A. Y. Bluestone, G. Abdoulaev, C. Schmitz, R. L. Barbour, and A. H. Hielscher, “Three-dimensional optical tomography of hemodynamics in the human head,” Opt. Express 9(6), 272–286 (2001).
[Crossref] [PubMed]

Hillman, E. M. C.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Hood, D. C.

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Hoshi, Y.

Y. Hoshi, “Functional near-infrared optical imaging: utility and limitations in human brain mapping,” Psychophysiology 40(4), 511–520 (2003).
[Crossref] [PubMed]

Iftimia, N.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Jiang, H.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Jöbsis, F. F.

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

Jobsis-Vandervliet, F. F.

F. F. Jobsis-Vandervliet, “Discovery of the near-infrared window into the body and the early development of near-infrared spectroscopy,” J. Biomed. Opt. 4(4), 392–396 (1999).
[Crossref] [PubMed]

Kato, Y.

Keshtgar, M.

Kilmer, M.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Klose, A. D.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Klove, K.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Lasker, J.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Leblond, F.

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

McCully, K. K.

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

Meek, J. H.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Miller, E. L.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Mishina, H.

Netz, U.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Nishidate, I.

Ntziachristos, V.

V. Ntziachristos, “Fluorescence molecular imaging,” Annu. Rev. Biomed. Eng. 8(1), 1–33 (2006).
[Crossref] [PubMed]

R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003).
[Crossref] [PubMed]

Obrig, H.

H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003).
[Crossref] [PubMed]

Okada, E.

Paulsen, K. D.

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003).
[Crossref] [PubMed]

Pogue, B. W.

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, “Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results,” Appl. Opt. 42(1), 135–145 (2003).
[Crossref] [PubMed]

Poplack, S. P.

Quaresima, V.

M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
[Crossref] [PubMed]

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

Richardson, C.

Schmitz, C.

Schweiger, M.

Shimizu, K.

Siegel, A. M.

Song, X.

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

Stewart, M.

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

Stott, J. J.

Styles, I. B.

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

Tochio, K.

Valdés, P. A.

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

Villringer, A.

H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003).
[Crossref] [PubMed]

Weissleder, R.

R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003).
[Crossref] [PubMed]

Wolf, M.

M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
[Crossref] [PubMed]

Wyatt, J. S.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Xu, Y.

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

Yamada, Y.

Yamamoto, K.

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

Yusof, R. M.

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Zhang, Q.

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

Zhao, H.

Annu. Rev. Biomed. Eng. (1)

V. Ntziachristos, “Fluorescence molecular imaging,” Annu. Rev. Biomed. Eng. 8(1), 1–33 (2006).
[Crossref] [PubMed]

Appl. Opt. (6)

Curr. Opin. Biotechnol. (1)

A. H. Hielscher, “Optical tomographic imaging of small animals,” Curr. Opin. Biotechnol. 16(1), 79–88 (2005).
[Crossref] [PubMed]

Dis. Markers (1)

A. H. Hielscher, A. Y. Bluestone, G. S. Abdoulaev, A. D. Klose, J. Lasker, M. Stewart, U. Netz, and J. Beuthan, “Near-infrared diffuse optical tomography,” Dis. Markers 18(5-6), 313–337 (2002).
[Crossref] [PubMed]

IEEE Signal Process. Mag. (1)

D. A. Boas, D. H. Brooks, E. L. Miller, C. A. DiMarzio, M. Kilmer, R. J. Gaudette, and Q. Zhang, “Imaging the body with diffuse optical tomography,” IEEE Signal Process. Mag. 18(6), 57–75 (2001).
[Crossref]

IEEE Trans. Biomed. Eng. (1)

B. D’Alessandro and A. P. Dhawan, “Transillumination imaging for blood oxygen saturation estimation of skin lesions,” IEEE Trans. Biomed. Eng. 59(9), 2660–2667 (2012).
[Crossref] [PubMed]

IEEE Trans. Med. Imaging (1)

H. Jiang, Y. Xu, N. Iftimia, J. Eggert, K. Klove, L. Baron, and L. Fajardo, “Three-dimensional optical tomographic imaging of breast in a human subject,” IEEE Trans. Med. Imaging 20(12), 1334–1340 (2001).
[Crossref] [PubMed]

J. Biomed. Opt. (4)

M. Wolf, M. Ferrari, and V. Quaresima, “Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications,” J. Biomed. Opt. 12(6), 062104 (2007).
[Crossref] [PubMed]

T. Hamaoka, K. K. McCully, V. Quaresima, K. Yamamoto, and B. Chance, “Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans,” J. Biomed. Opt. 12(6), 062105 (2007).
[Crossref] [PubMed]

F. F. Jobsis-Vandervliet, “Discovery of the near-infrared window into the body and the early development of near-infrared spectroscopy,” J. Biomed. Opt. 4(4), 392–396 (1999).
[Crossref] [PubMed]

B. W. Pogue, S. C. Davis, X. Song, B. A. Brooksby, H. Dehghani, and K. D. Paulsen, “Image analysis methods for diffuse optical tomography,” J. Biomed. Opt. 11(3), 033001 (2006).
[Crossref] [PubMed]

J. Cereb. Blood Flow Metab. (1)

H. Obrig and A. Villringer, “Beyond the visible--imaging the human brain with light,” J. Cereb. Blood Flow Metab. 23(1), 1–18 (2003).
[Crossref] [PubMed]

J. Photochem. Photobiol. B (1)

F. Leblond, S. C. Davis, P. A. Valdés, and B. W. Pogue, “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications,” J. Photochem. Photobiol. B 98(1), 77–94 (2010).
[Crossref] [PubMed]

Meas. Sci. Technol. (1)

J. A. Guggenheim, H. R. A. Basevi, J. Frampton, I. B. Styles, and H. Dehghani, “Multi-modal molecular diffuse optical tomography system for small animal imaging,” Meas. Sci. Technol. 24(10), 105405 (2013).
[Crossref]

Med. Biol. Eng. Comput. (1)

M. Cope and D. T. Delpy, “System for long-term measurement of cerebral blood and tissue oxygenation on newborn infants by near infra-red transillumination,” Med. Biol. Eng. Comput. 26(3), 289–294 (1988).
[Crossref] [PubMed]

Nat. Med. (1)

R. Weissleder and V. Ntziachristos, “Shedding light onto live molecular targets,” Nat. Med. 9(1), 123–128 (2003).
[Crossref] [PubMed]

Opt. Express (1)

Opt. Lett. (3)

Philos Trans A Math Phys Eng Sci (1)

A. Gibson and H. Dehghani, “Diffuse optical imaging,” Philos Trans A Math Phys Eng Sci 367(1900), 3055–3072 (2009).
[Crossref] [PubMed]

Phys. Med. Biol. (3)

A. P. Gibson, J. C. Hebden, and S. R. Arridge, “Recent advances in diffuse optical imaging,” Phys. Med. Biol. 50(4), R1–R43 (2005).
[Crossref] [PubMed]

J. C. Hebden, S. R. Arridge, and D. T. Delpy, “Optical imaging in medicine: I. Experimental techniques,” Phys. Med. Biol. 42(5), 825–840 (1997).
[Crossref] [PubMed]

J. C. Hebden, A. Gibson, R. M. Yusof, N. Everdell, E. M. C. Hillman, D. T. Delpy, S. R. Arridge, T. Austin, J. H. Meek, and J. S. Wyatt, “Three-dimensional optical tomography of the premature infant brain,” Phys. Med. Biol. 47(23), 4155–4166 (2002).
[Crossref] [PubMed]

Psychophysiology (2)

Y. Hoshi, “Functional near-infrared optical imaging: utility and limitations in human brain mapping,” Psychophysiology 40(4), 511–520 (2003).
[Crossref] [PubMed]

G. Gratton, P. M. Corballis, E. Cho, M. Fabiani, and D. C. Hood, “Shades of gray matter: noninvasive optical images of human brain responses during visual stimulation,” Psychophysiology 32(5), 505–509 (1995).
[Crossref] [PubMed]

Science (1)

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

Surg. Gynecol. Obstet. (1)

M. Cutler, “Transillumination as an aid in the diagnosis of breast lesions,” Surg. Gynecol. Obstet. 48, 721–728 (1929).

Other (5)

R. Bright, Diseases of the brain and nervous system vol. II (London: Longman, 1831).

T. B. Curling, A practical treatise on the diseases of the testis and of the spermatic cord and scrotum (London: Samuel Highley, 1843).

Y. Taka, Y. Kato, and K. Shimizu, “Transillumination imaging of physiological functions by NIR light,” in Proceedings of IEEE Conference on 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE, 2000), pp. 771–774.
[Crossref]

R. J. Hanisch, R. L. White, and R. L. Gilliland, “Deconvolution of hubble space telescope images and spectra,” in Deconvolution of Images and Spectra, P.A. Jansson, ed. (Academic Press, Boston, MA, 1997).

Science Council of Japan, Guidelines for proper conduct of animal experiments (2006).

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (26)

Fig. 1
Fig. 1 Geometry for PSF as light distribution observed at the scattering medium surface.
Fig. 2
Fig. 2 Experimental setup for transillumination imaging: d = 4.00–14.0 mm.
Fig. 3
Fig. 3 Comparison of point spread function at depth d = 8.00 mm: (a) fs(x, y), (b) fo(x, y), (c) PSFabs(x, y) from Eq. (2), (d) PSF from Eq. (1).
Fig. 4
Fig. 4 Comparison between theoretical PSF for light source and measured PSF for absorber.
Fig. 5
Fig. 5 Transillumination image: (a) original object, (b) observed image, (c) deconvoluted image.
Fig. 6
Fig. 6 Intensity profiles along the dashed line in Fig. 5.
Fig. 7
Fig. 7 Experimental setup.
Fig. 8
Fig. 8 Side view and top view of phantom model.
Fig. 9
Fig. 9 Observed and deconvoluted images of absorber: (a) observed image (contrast and sharpness are 0.10 and 0.020), (b) deconvoluted image (contrast and sharpness are 0.90 and 0.71).
Fig. 10
Fig. 10 CT image at the top of the absorber: (a) from observed images, (b) from deconvoluted images. Depth of estimated absorber center ( d ^ ) was 9.35 mm for true depth 9.08 mm.
Fig. 11
Fig. 11 CT image at the bottom of the absorber: (a) from observed images, (b) from deconvoluted images. Depth of estimated absorber center ( d ^ ) was 12.1 mm for true depth 12.2 mm.
Fig. 12
Fig. 12 3D Reconstruction of absorber in turbid medium: (a) from observed images, (b) from deconvoluted images, (c) result of thresholding on image (b) with a single threshold value.
Fig. 13
Fig. 13 Observed and deconvoluted images of absorber at 0-deg orientation: (a) observed image (b) result using the proposed technique.
Fig. 14
Fig. 14 3D Reconstruction of absorber in animal tissue: (a) from observed images, (b) from deconvoluted images, (c) result of thresholding on image (b) with a single threshold value.
Fig. 15
Fig. 15 Two absorbing objects in turbid medium: (a) top view of observing condition, (b) observed transillumination image and absorption profile along the dashed line.
Fig. 16
Fig. 16 Absorption profiles before and after the deconvolution with PSFs at different depths. The projection is obtained as a sum of the deconvoluted data with the PSFs at different depths. Profile of projection for cross-sectional reconstruction is shown in upper right corner. denotes the deconvolution operation.
Fig. 17
Fig. 17 Principle to suppress erroneous absorption distribution. Erroneous parts are suppressed by multiplying erasing templates obtained from the original cross-sectional image. New projection image is constructed as a sum of the corrected images. * denotes the multiplication operation.
Fig. 18
Fig. 18 Result of proposed technique in simulation: (a) simulation model (μ's = 1.00 /mm, μa = 0.00536 /mm), (b) cross-sectional image of two objects in scattering medium, (c) result from projection of Eq. (3), (d) result from projection of Eq. (4).
Fig. 19
Fig. 19 Experimental setup with phantom.
Fig. 20
Fig. 20 Scattering suppression in transillumination imaging at 0-deg orientation: (a) observed image in clear medium, (b) observed image in scattering medium, (c) result using the proposed technique.
Fig. 21
Fig. 21 Scattering suppression in transillumination imaging at 90-deg orientation: (a) observed image in clear medium, (b) observed image in scattering medium, (c) result using the proposed technique.
Fig. 22
Fig. 22 3D images reconstructed from transillumination images: (a) from observed image in clear medium, (b) from observed image in scattering medium, (c) result using the proposed technique.
Fig. 23
Fig. 23 Setup for experiment with living animal.
Fig. 24
Fig. 24 Suppression of body-surface illumination caused by light-guide effect in cylindrical container: (a) without light trap, (b) with light trap, (c) light trap structure.
Fig. 25
Fig. 25 Transillumination images of mouse abdomen: (a) observed image, (b) deconvoluted image with PSF (μ's = 1.5 /mm, μa = 0.02 /mm).
Fig. 26
Fig. 26 3D images reconstructed from transillumination images of mouse: (a) from observed images, (b) result using the proposed technique.

Equations (4)

Equations on this page are rendered with MathJax. Learn more.

PSF(ρ)= 3 P 0 (4π) 2 { (μ ' s + μ a )+ [ κ d + 1 ( ρ 2 + d 2 ) 1/2 ] d ( ρ 2 + d 2 ) 1/2 } exp [ κ d ( ρ 2 + d 2 ) 1/2 ] ( ρ 2 + d 2 ) 1/2 ,
PS F abs (x,y)= f s (x,y) f o (x,y),
P(x,z|θ)= i=1 n A(x,y,z|θ)dy PSF(x,z| d i ),
P new (x,z|θ)= i=1 n [ A(x,y,z|θ)dy PSF(x,z| d i ) ]E(x,z|θ, d i ) ,

Metrics